CD274 and type 1 diabetes mellitus: Concurrently, immune-senescence-related pro-inflammatory pathways, including T cell receptor signaling, programmed death-ligand 1 (PD-L1) checkpoint, type I diabetes, and NF-κB signaling, were significantly suppressed, an indication of reduced vascular inflammation.